Exhibit 23.2
|
|
|
|
|
KPMG LLP Two Financial Center 60 South Street Boston, MA 02111 |
Consent of Independent Registered Public Accounting Firm
We consent to the use of our reports dated February 27, 2025, with respect to the consolidated financial statements of Cullinan Therapeutics, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.
|
/s/ KPMG LLP |
Boston, Massachusetts |
February 27, 2025 |